Eight Years of Lung Transplantation: Experience of the National Research Institute of Tuberculosis and Lung Diseases

Transplantation Proceedings

Volumn 41, Issue 7, 2009, Pages 2887-2889

  Shadmehr, M B ^a   Arab, M ^a   Pejhan, S ^a   Daneshvar, A ^a   Javaherzadeh, N ^a   Abbasi, A ^a   Ahmadi, Z H ^a   Radpay, B ^a   Dabir, S ^a   Parsa, T ^a   Mohammadi, F ^a   Mansoori, S D ^a   Tabarsi, P ^a   Amiri, M Valiollahpour ^a   Marjani, M ^a   Kashani, B Sharif ^a   Najafizadeh, K ^a   Shafaghi, S ^a   Ghorbani, F ^a   Masjedi, M R ^a   Velayati, A A ^a   more..

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; CEPHALOSPORIN; CIPROFLOXACIN; CYCLOSPORIN A; GANCICLOVIR; MEROPENEM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PYRROLE DERIVATIVE; TOBRAMYCIN; VALGANCICLOVIR; VANCOMYCIN;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; BLEEDING; BONE; BRONCHIECTASIS; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CYSTIC FIBROSIS; DEATH; DEVELOPING COUNTRY; DRUG DOSE TITRATION; ERGOMETRY; EXPERIENCE; FAT EMBOLISM; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HEALTH CARE ORGANIZATION; HEMODYNAMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; IRAN; LABORATORY TEST; LUNG FIBROSIS; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; MYCOSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SPIROMETRY; SURVIVAL TIME; THORAX RADIOGRAPHY; VIRUS INFECTION;

ADOLESCENT; ADULT; CAUSE OF DEATH; DEVELOPING COUNTRIES; FEMALE; HUMANS; IRAN; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS; YOUNG ADULT;

EID: 70149122369     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.07.016     Document Type: Article

References (11)

1. Ver F., Fullerton D.A., Zamora M.R., et al. The past, present and future of lung transplantation. Am J Surg 173 (1997) 553
2. Maurer J.R., Frost A.E., Estenne M., et al. International Society for Heart and Lung Transplantation, the American Thoracic Society of Transplant Physicians, the European Respiratory Society: International guidelines for the selection of lung transplant candidates. J Heart Lung Transplant 17 (2007) 703
3. Speich R., Boehler A., Spiliopoulos A., Weder W., and Nicod L.P. Indication for Lung transplantation in advanced cystic fibrosis. Schweiz Med Wochenschr 130 (2000) 1352
4. Patterson G.A., Cooper J.D., Goldman B., et al. Technique of successful clinical double lung transplantation. Ann Thorac Surg 45 (1988) 626
5. Nicod L., Spiteri M.A., Taylor D.O., et al. How infections can modify lung immunity. Eur Respir J 18 (2000) 442
6. Rothmeier C., Roux E., Spiliopoulos A., et al. Early chimerism of macrophages and lymphocytes in lung transplant recipients is predictive of graft tolerance. Transplantation 71 (2001) 1324
7. Gerbase M.W., Spiliopoulos A., Fathi M., et al. Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation. Transplant Proc 33 (2001) 2146
8. Hamacher J., Spiliopoulos A., Kur A.M., et al. Geneva Lung Transplantation Group: Pre-emptive therapy with azoles in lung transplant patients. Eur Respir J 13 (1999) 180
9. Nicod L.P., Pache J.C., and Howarth N. Fungal infections in transplant recipients. Eur Respir J 17 (2001) 133
10. Gerbase M.W., Dubois D., Rothmeier C., et al. Costs and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation. Chest 116 (1999) 1265
11. van der Bij W., and Speich R. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin Infect Dis 33 (2001) S32